REQUEST A DEMO
Total
USD $0.00
Search more companies

Alvartis Pharma Ecuador S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing
Full name: Alvartis Pharma Ecuador S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Alvartis Pharma Ecuador S.A. is an enterprise based in Ecuador. Its main office is in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Alvartis Pharma Ecuador S.A. was incorporated on March 19, 2019. Alvartis Pharma Ecuador S.A. currently employs 4 (2020) people. From the latest financial highlights, Alvartis Pharma Ecuador S.A. reported a net sales revenue drop of 28.45% in 2021. Its’ total assets recorded a negative growth of 17.85%. The enterprise’s net profit margin decreased by 1.07% in 2021.

Headquarters
Cdla. Kennedi Norte S.01 Mz. 807 Solar 1
Guayaquil; Guayas;

Contact Details: Purchase the Alvartis Pharma Ecuador S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Alvartis Pharma Ecuador S.A. report to view the information.
Outstanding Shares:
Purchase the Alvartis Pharma Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Alvartis Pharma Ecuador S.A. report to view the information.
Incorporation Date:
March 19, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
26%
Purchase this report to view the information.
24%
Company Performance
Financial values in the chart are available after Alvartis Pharma Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-28.45%
Total operating revenue
-28.45%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-32.61%
Total assets
-17.85%
Total equity
-0.72%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-1.07%
Return on Equity (ROE)
-0.75%
Debt to Equity Ratio
1046.54%
Quick Ratio
4.41%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?